Effects of Berry Nectars Sweetened With Inverted Sugar on Post-meal Blood Sugar

NCT ID: NCT02743130

Last Updated: 2016-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Berries have been shown to improve postprandial glucose and insulin responses to sucrose. During processing and storage of berry products, sucrose is inverted to glucose and fructose. The effects of berries on the glycemic response induced by inverted sugar are not known. The purpose of this study is to determine whether berries are effective in lowering the postprandial glucose and insulin responses induced by inverted sugar.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperglycemia, Postprandial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blackcurrant nectar

Contains 17.5 g glucose and 17.5 g fructose representing 35 g completely inverted sucrose

Group Type EXPERIMENTAL

Blackcurrant Nectar

Intervention Type DIETARY_SUPPLEMENT

Consumption of a single dose (300 ml)

Lingonberry nectar

Contains 17.5 g glucose and 17.5 g fructose representing 35 g completely inverted sucrose

Group Type EXPERIMENTAL

Lingonberry Nectar

Intervention Type DIETARY_SUPPLEMENT

Consumption of a single dose (300 ml)

Reference

Sugar control, contains 17.5 g glucose and 17.5 g fructose in water

Group Type ACTIVE_COMPARATOR

Reference

Intervention Type DIETARY_SUPPLEMENT

Consumption of a single dose (300 ml)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blackcurrant Nectar

Consumption of a single dose (300 ml)

Intervention Type DIETARY_SUPPLEMENT

Lingonberry Nectar

Consumption of a single dose (300 ml)

Intervention Type DIETARY_SUPPLEMENT

Reference

Consumption of a single dose (300 ml)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI 20-28 kg/m2
* Normal fasting plasma glucose

Exclusion Criteria

* Smoking
* Diabetes or other chronic disease
* Antibiotic medication within the past 3 months
* Blood donation within the past month
Minimum Eligible Age

25 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Finnsugar Ltd

UNKNOWN

Sponsor Role collaborator

University of Eastern Finland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Riitta Törrönen

Senior Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Riitta Törrönen, Dr

Role: PRINCIPAL_INVESTIGATOR

Senior Scientist

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Eastern Finland

Kuopio, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INVE 903/020502/2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.